Safety of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, Rotarix When Administered According to the Prescribing Information in Korea.
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2014
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 06 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2012 Actual patient number changed from 876 to 1052 according to ClinicalTrials.gov.
- 24 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.